T cell proliferation and inhibiting IL-2 and TNF production. We conclude that Acan1 and Nak1 warrant further development as therapeutics for the treatment of autoimmunity, particularly gastrointestinal inflammatory conditions.
Authors | Smallwood, Taylor B; Navarro, Severine; Cristofori-Armstrong, Ben; Watkins, Thomas S; Tungatt, Katie; Ryan, Rachael Ym; Haigh, Oscar L; Lutzky, Viviana P; Mulvenna, Jason P; Rosengren, K Johan; Loukas, Alex; Miles, John J; Clark, Richard J |
---|---|
Journal | Journal of Biological Chemistry |
Pages | 100834 |
Volume | 297 |
Date | 1/01/2021 |
Grant ID | |
Funding Body | |
URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016/j.jbc.2021.100834 |